NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer

Clinical trial NCT00856375 · COMPLETED

Trial details

NCT number: NCT00856375
Sponsor: Nektar Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2008-12-01
Primary completion: 2014-07-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.